Steven Basta Net Worth

The estimated Net Worth of Steven L Basta is at least $204 dollars as of 11 December 2019. Mr. Basta owns over 252,800 units of Viveve Medical Inc stock worth over $204 and over the last 7 years he sold VIVE stock worth over $0. In addition, he makes $0 as Independent chairman of the Board at Viveve Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. Basta VIVE stock SEC Form 4 insiders trading

Steven has made over 1 trades of the Viveve Medical Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 252,800 units of VIVE stock worth $25,280 on 11 December 2019.

The largest trade he's ever made was exercising 252,800 units of Viveve Medical Inc stock on 11 December 2019 worth over $25,280. On average, Steven trades about 13,305 units every 0 days since 2018. As of 11 December 2019 he still owns at least 509,764 units of Viveve Medical Inc stock.

You can see the complete history of Mr. Basta stock trades at the bottom of the page.

Steven Basta biography

Steven L. Basta serves as Independent chairman of the Board of the Company. Mr. Basta joined the Viveve board in September of 2018 and was appointed chairman of the board in January 2019. He served as president, chief executive officer, and director of Menlo Therapeutics, Inc., a publicly listed biopharmaceutical company that develops and commercializes treatments for dermatologic and other chronic conditions from 2015 to March 2020. From October 2011 until August 2015, Mr. Basta served as chief executive officer of AlterG, Inc., a privately held medical device company. From November 2002 to February 2010, Mr. Basta served as chief executive officer of BioForm Medical, Inc., a publicly listed medical aesthetics company acquired by Merz and from February 2010 to September 2011 served as chief executive officer of Merz Aesthetics, the successor to BioForm Medical, where he led multiple product launches managing the global business to reach its position as a worldwide leader in the injectable aesthetics industry. He served on the board of Carbylan, Inc. from September 2009 to November 2016 and the board of RF Surgical, Inc. (acquired by Medtronic) from December 2013 to August 2015. Mr. Basta received a B.A. from The Johns Hopkins University and an M.B.A. from the Kellogg Graduate School of Management at Northwestern University.

How old is Steven Basta?

Steven Basta is 53, he's been the Independent chairman of the Board of Viveve Medical Inc since 2019. There are 7 older and 3 younger executives at Viveve Medical Inc. The oldest executive at Viveve Medical Inc is Arlene Morris, 68, who is the Independent Director.

What's Steven Basta's mailing address?

Steven's mailing address filed with the SEC is 200 Cardinal Way 2ND FLOOR, Redwood City, CA 94063, USA.

Insiders trading at Viveve Medical Inc

Over the last 8 years, insiders at Viveve Medical Inc have traded over $444,564 worth of Viveve Medical Inc stock and bought 3,021,700 units worth $13,021,042 . The most active insiders traders include Sachs Group Incgoldman Sach..., Daniel Janney, and Capital Management, Llcston.... On average, Viveve Medical Inc executives and independent directors trade stock every 80 days with the average trade being worth of $83. The most recent stock trade was executed by Sachs Group Incgoldman Sach... on 30 September 2019, trading 92,425 units of VIVE stock currently worth $444,564.

What does Viveve Medical Inc do?

viveve provides women low risk, high reward medical procedures that promote personal health and wellness. the company is committed to innovative technological advances and to broad and elucidating education for medical and lay audiences worldwide.

Complete history of Mr. Basta stock trades at Viveve Medical Inc and Menlo Therapeutics

Viveve Medical Inc executives and stock owners

Viveve Medical Inc executives and other stock owners filed with the SEC include:

• Scott Durbin,
  Chief Executive Officer, Director
• Sean Shapiro,
  Vice President - U.S. Sales
• Scott C. Durbin,
  CEO & Director
• Jim Robbins,
  Principal Financial Officer and Administration, Principal Accounting and Financial Officer
• Jim B. Robbins,
  Sr. VP of Fin. & Admin. and Principal Accounting & Financial Officer
• Deborah Ann Jorn M.B.A.,
  Sr. Advisor to the CEO & Director
• Debora Ann Jorn M.B.A.,
  Sr. Advisor to the CEO & Director
• Sharon Presnell,
  Independent Director
• Arlene Morris,
  Independent Director
• Debora Jorn,
  Director
• Steven Basta,
  Independent chairman of the Board
• Suzon D. Lommel,
  Sr. VP of Regulatory & Quality Affairs
• Lori McMillan,
  VP of HR
• Gary Kaiser,
  VP of Global Marketing
• Jeff Sinclair,
  VP of International Sales
• Jeannie Swindle,
  Sr. Director of Corp. Communications
• Martin Kerber P.E.,
  VP of Research, Devel. & Operations
• Daniel Janney,
  Director
• Patricia Scheller,
  Chief Executive Officer
• Lori H Bush,
  Director
• Brigitte Smith,
  Director
• Jon M Plexico,
  Director
• Capital Management, Llcston...,
  Director
• Karen L. Zaderej,
  Director
• James G. Atkinson,
  CBO & President
• Sachs Group Incgoldman Sach...,